Global dementia cases will nearly TRIPLE to more than 152 million by 2050, grim study predicts
- University of Washington scientists based estimations on dementia risk factors
- They claim the increase will be driven in part by an ageing and rising population
- Currently there are 50 million people living with dementia globally, WHO claims
Global dementia cases will nearly triple to reach more than 152 million by 2050, driven by an ageing population, a new study predicts.
University of Washington researchers have based their estimation on trends in dementia risk factors, such as smoking and high body mass index (BMI).
They claim dementia cases will increase from an estimated 57.4 million globally in 2019 to an estimated 152.8 million cases in 2050.
The highest increase in dementia prevalence is projected to be in eastern sub-Saharan Africa, North Africa and the Middle East, they add.
According to the World Health Organisation (WHO), there around 50 million people with dementia globally, and there are nearly 10 million new cases every year.

Rising dementia cases are due to an ageing population and lifestyle factors including smoking, high mass index and high blood sugar
There are multiple diseases that cause dementia, which is classified as the impaired ability to remember, think or make decisions that interferes with doing everyday activities.
According to the new study, positive trends in access to education are expected to decrease dementia prevalence worldwide by 6.2 million cases by 2050.
But this figure is more than cancelled out by anticipated trends in smoking, high BMI and high blood sugar, which combined are predicted to increase dementia prevalence by 6.8 million cases by 2050.
The research was led by Emma Nichols, an expert with the Institute for Health Metrics and Evaluation at the University of Washington School of Medicine.
'These estimates will allow policymakers and decision makers to better understand the expected increases in the number of individuals with dementia as well as the drivers of these increases in a given geographical setting,' she said.
'The large anticipated increase in the number of individuals with dementia emphasises the vital need for research focused on the discovery of disease-modifying treatments and effective low-cost interventions for the prevention or delay of dementia onset.'
The new forecast matches those from the WHO, which has already put the number of global dementia cases at 152 million by 2050.
'Our forecasts were developed independently from those released by the WHO in 2017, and additionally incorporated information on expected trends in risk factors,' Nichols told MailOnline.
'Therefore, the two sets of results can be seen as convergent evidence highlighting the importance of dementia as a public health issue moving into the future.'
Nichols and colleagues used data from 1999 to 2019 from the Global Burden of Disease (GBD) study, a comprehensive set of estimates of health trends worldwide.
Their study aimed to improve on prior forecasts by incorporating information on trends in dementia risk factors.
The team used the same data set to estimate that Alzheimer's mortality rates increased by 38 per cent between 1990 and 2019.
The study is being presented at this week's Alzheimer's Association International Conference (AAIC), which is being held in Denver and live-streamed online.
'Improvements in lifestyle in adults in developed countries and other places –including increasing access to education and greater attention to heart health issues – have reduced incidence in recent years,' said Maria C. Carrillo, Alzheimer's Association chief science officer.
'But total numbers with dementia are still going up because of the ageing of the population.

There are different diseases that can cause dementia. Many are associated with an abnormal build-up of proteins in the brain. This build-up causes nerve cells to function less well and ultimately die (stock image)
'In addition, obesity, diabetes and sedentary lifestyles in younger people are rising quickly, and these are risk factors for dementia.
'Without effective treatments to stop, slow or prevent Alzheimer's and all dementia, this number will grow beyond 2050 and continue to impact individuals, caregivers, health systems and governments globally.
'In addition to therapeutics, it's critical to uncover culturally-tailored interventions that reduce dementia risk through lifestyle factors like education, diet and exercise.'
According to predictions from Alzheimer's Research UK, one million people in the country will have dementia by 2025, doubling to two million by 2050.
However, some UK-focused research has pointed to a potential drop in the proportion of people living with dementia in any given age group, possibly due to improved levels of education and less smoking.
'Dementia is our greatest long-term medical challenge,' Hilary Evans, chief executive of the organisation, told PA news.
'These striking figures lay bare the shocking scale of dementia on a global scale.'
Another study presented on Tuesday at AAIC investigates younger-onset dementia (YOD), a form of dementia where the onset of symptoms happens before age 65.
Unfortunately, data on YOD is extremely limited, according to a team of experts at Maastricht University in the Netherlands.
So they conducted a review of all studies published during the past 30 years that reported figures on how many people developed dementia before the age of 65.
Overall, an estimated 10 in every 100,000 individuals develop dementia with early onset, or prior to age 65.
This corresponds to 350,000 new cases of early onset dementia per year, globally.
Incidence rates for men and women were similar, and were highest for Alzheimer's disease – the most common form of dementia – followed by vascular dementia and frontotemporal dementia.
'Our findings should raise awareness in healthcare professionals, researchers and policy makers because they show that a significant number of people are newly affected by young-onset dementia every year,' said study leader Stevie Hendriks at Maastricht University.
'This shows the need for investment in tailored healthcare for this special patient group and more research into how we can best support but also prevent and treat young-onset dementia.'